Moat Ross Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
5
Insider Sells Sum
$4.6M

Insider Activity of Moat Ross

According to the SEC Form 4 filings, Moat Ross, being in a position of

  1. CHIEF OPERATING OFFICER at Kiniksa Pharmaceuticals International, plc,
    оver the last 12 months, has bought 0 shares, and sold 107655 shares for $9.82M,
    over all time since 2024-09-03, has bought 0 shares, and sold 319078 shares for $15.35M.

Biography of Moat Ross

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$9,820,2924100

Comparison of Insiders on Amount of Buys and Sells

2026-11-02SaleKiniksa Pharmaceuticals International, plc
KNSA
CHIEF OPERATING OFFICER
27,977
0.0364%
$92.36$2.58M+1%
2026-10-30SaleKiniksa Pharmaceuticals International, plc
KNSA
CHIEF OPERATING OFFICER
75,608
0.0976%
$93.13$7.04M
2026-04-09SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF OPERATING OFFICER
1,703
0.0022%
$46.69$79,513+37.48%
2026-04-06SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF OPERATING OFFICER
2,367
0.0031%
$48.58$114,989+30.23%
2025-09-04SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF CORP. & COMM. OFFICER
3,523
0.0047%
$35.31$124,397+27.77%
2025-06-03SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF COMMERCIAL OFFICER
27,594
0.0377%
$29.02$800,778+40.85%
2025-05-05SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF COMMERCIAL OFFICER
6,272
0.0087%
$28.00$175,616+40.03%
2025-05-01SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF COMMERCIAL OFFICER
23,234
0.0322%
$28.02$651,017+40.05%
2025-04-29SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF COMMERCIAL OFFICER
64,035
0.0856%
$25.21$1.61M+49.81%
2025-04-21SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF COMMERCIAL OFFICER
18,259
0.0251%
$20.29$370,475+92.22%
2024-09-03SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHIEF COMMERCIAL OFFICER
68,506
0.0966%
$26.12$1.79M-7.73%
Total: 11
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.